Keck Medicine of USC has become the world’s first medical center to implant a responsive brain device newly approved by the Food and Drug Administration (FDA) to treat epilepsy. It has the potential to help millions of people worldwide.
The treatment involves surgical implantation of a device that detects and then directly responds to abnormal brain activity to prevent seizures before they occur. In a three-hour surgery Dec. 18, USC faculty physicians implanted the device in a 28-year-old Lakewood, Calif., woman who was diagnosed with epilepsy in 2004.
